RFI: Notice of Intent to Sole Source - Annual Genetics Referral Lab Testing

This is a Special Notice for commercial items prepared in accordance with FAR Subpart 5.2, Synopsis of Proposed Contract Actions. This announcement constitutes the only Notice of Intent (NOI) to Sole Source (SS) and synopsis of proposed action.

The Department of Veterans Affairs Michael E. DeBakey VA Medical Center (MEDVAMC) Network Contracting Office (NCO) 16 intends to issue and award a Sole Source single award Firm-Fixed Price type contract with a performance period of five (5) 12 month ordering periods not to exceed (NTE) five (5) years to Fulgent Therapeutics LLC located at 4978 Santa Anita AVE STE 205 Temple City CA 91780-3600, for generic testing at the MEDVAMC, located at 2002 Holcombe Boulevard, Houston, TX 77030. It has been determined that through initial Market Research, only 1 (one) responsible source can provide the required testing as identified below.

The contract will be a Firm Fixed Price single award. The statutory authority for this non-competitive acquisition as implemented by FAR 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements . The North American Industrial Classification System (NAICS) code for this procurement is 541714 Research and Development in Biotech, with a small business size standard of 1,000 employees, and the FSC/PSC is 6632 Analysis Instruments, Medical Laboratory Use.

The Department of Veterans Affairs intends to solicit and award IAW FAR 13.5 a sole source firm fixed standalone contract award to provide referral genetic testing see attached Special Notice announcement NOI SS for further details.